Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia
NCT ID: NCT01461590
Last Updated: 2015-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
160 participants
INTERVENTIONAL
2011-10-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Full Assessment of Clinical Transfusion Support
NCT07094646
RBC Transfusion in Severe Anemia With Lactic Acidosis
NCT01586923
Effect of Blood Storage Age on the Resolution of Lactic Acidosis in Children With Severe Malarial Anemia at Mulago Hospital
NCT01580111
A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia
NCT06678165
Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)
NCT03948867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We evaluated the safety and efficacy of a higher volume of whole blood (30 ml/kg; Tx30: n = 78) against the standard volume (20 ml/kg; Tx20: n = 82) in Ugandan children (median age 35.5 months (interquartile range (IQR) 12.5 to 52.5)) for 24-hour anemia correction (hemoglobin \>6 g/dl: primary outcome) and 28-day survival.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
20ml/kg of whole blood transfusion
Standard care recommended by WHO
Whole blood
30mls/kg transfused over fours hours
Whole blood
20mls/kg transfused over four hours
30ml/kg of whole blood
Higher volume than currently recommended
Whole blood
30mls/kg transfused over fours hours
Whole blood
20mls/kg transfused over four hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole blood
30mls/kg transfused over fours hours
Whole blood
20mls/kg transfused over four hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Guardian or parent willing/able to provide consent
Exclusion Criteria
* Surgery
* Acute trauma
* Severe malnutrition
60 Days
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Prof Kathryn Maitland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Kathryn Maitland
Professor in Infectious Diseases and Critical Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Engoru, MMed, MBChB
Role: PRINCIPAL_INVESTIGATOR
Soroti Regional Hospital, Uganda
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mbale Regional Referral Hospital
Mbale, Mbale, Uganda
Soroti Regional Hospital
Soroti, Soroti, Uganda
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Olupot-Olupot P, Engoru C, Thompson J, Nteziyaremye J, Chebet M, Ssenyondo T, Dambisya CM, Okuuny V, Wokulira R, Amorut D, Ongodia P, Mpoya A, Williams TN, Uyoga S, Macharia A, Gibb DM, Walker AS, Maitland K. Phase II trial of standard versus increased transfusion volume in Ugandan children with acute severe anemia. BMC Med. 2014 Apr 25;12:67. doi: 10.1186/1741-7015-12-67.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEMRI_CT_2011/0015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.